Global /United States /Healthcare /Biotechnology /ANIP
chevron_leftBack
ANI Pharmaceuticals, Inc. logo

ANI Pharmaceuticals, Inc.

ANIP
NASDAQ: ANIP Delayed
77.97USD -0.7%
As of 13 June 2026, ANI Pharmaceuticals, Inc. has a market cap of $1.77B USD, ranking #7625 globally and #1780 in the United States. It ranks #623 in the Healthcare sector, and #119 in the Biotechnology industry.
Global Rank
7625
Country Rank
1780
Sector Rank
623
Industry Rank
119
Key Stats
Market Cap
$1.77BUSD
Enterprise Value
$2.11BUSD
Revenue (TTM)
$883.37MUSD
EBITDA (TTM)
$174.75MUSD
Net Income (TTM)
$70.22MUSD
EBITDA Margin
20%
Profit Margin
8.9%
PE Ratio
23.5
Forward PE
8.6
PS Ratio
2.0
PB Ratio
3.0
EV/EBITDA
12.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Nikhil Lalwani open_in_new
Employees
970
Founded
2001
Website
anipharmaceuticals.com open_in_new
1d 1w 1m 3m 6m 1y
-0.7% -2.6% 7.2% -1.8% -16% 10%

News

Loading...

ANIP Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NASDAQ
MIC: XNAS
PRIMARY
ANIP
ANI Pharmaceuticals Inc
ISIN: US00182C1036
Shares Out.:
22.735M1 Shares Float: 19.954M2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
77.97 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Similar Companies

Industry: Biotechnology (United States)
Name
Market Cap diff.
PE
AMGN
$182.42B
10K%
23.9
GILD
$159.92B
9K%
19.0
NTRA
$27.6B
1K%
-
$26.3B
1K%
20.0
$25.03B
1K%
20.4
MRNA
$18.13B
922%
-
Industry: Biotechnology (Global)
Name
Market Cap diff.
PE
ARGX
$47.84B
41.39B EUR
3K%
39.9
$44.84B
68.19T KRW
2K%
35.5
CSL
$42.36B
60.27B AUD
2K%
29.3
LONN
$42.3B
33.71B CHF
2K%
37.2
068270
$28.11B
42.76T KRW
1K%
43.8
BNTX
$25.69B
1K%
-
chevron_leftBack